At the news
? NEUTRALIMPACT 4/10 8-K filed Apr 24, 2026 at 07:11 ET
HCA Healthcare reported Q1 2026 results with revenue of $19.109 billion (4.3% YoY growth) and diluted EPS of $7.15, matching consensus. The company reaffirmed its full-year 2026 guidance and repurchased $1.571 billion in shares. Despite lower respiratory volumes, Medicaid supplemental program recognition offset impacts.
- Q1 2026 revenue was $19.109 billion, up 4.3% YoY
- Diluted EPS was $7.15, up 10.9% YoY and in line with consensus of $7.15
- Adjusted EBITDA increased 1.9% to $3.802 billion
- Company reaffirmed 2026 full-year guidance: EPS $29.10–$31.50, revenue $76.5–80.0 billion
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access